# BUPRENORPHINE AND NALOXONE

NDC: 67877-607
Generic name: BUPRENORPHINE AND NALOXONE
Labeler / Manufacturer: Ascend Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: SUBLINGUAL
Marketing started: 20260703

FDA application: ANDA214930

## Active ingredients

- BUPRENORPHINE HYDROCHLORIDE: 2 mg/1
- NALOXONE HYDROCHLORIDE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67877-607"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67877-607
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2e807ed0-6df3-47b5-b7ee-b421c5bf0aa7